Insider · CIK 0001832343

Zaremba Rabourn Amy

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001832343

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-23	IRDOpus Genetics, Inc.S Sale	Head of Fin. Quality Assurance	SSale	−1,641 sh	$5.20	−$8,539.764	188,671
2026-03-16	IRDOpus Genetics, Inc.S Sale	Head of Fin. Quality Assurance	SSale	−2,816 sh	$5.25	−$14.8K	190,312
2026-01-22	IRDOpus Genetics, Inc.A Award	Head of Fin. Quality Assurance	AAward	+86.5K sh	—	—	193,128
2026-01-18	IRDOpus Genetics, Inc.F Tax Payment	Head of Fin. Quality Assurance	FTax Payment	−3,390 sh	$2.10	−$7,119	106,628
2026-01-10	IRDOpus Genetics, Inc.F Tax Payment	Head of Fin. Quality Assurance	FTax Payment	−3,950 sh	$1.93	−$7,623.5	110,018
2025-03-13	IRDOpus Genetics, Inc.A Award	Head of Fin. Quality Assurance	AAward	+39.5K sh	—	—	113,968
2025-03-13	IRDOpus Genetics, Inc. · Employee Stock Option (right to buy)A Award	Head of Fin. Quality Assurance	AAward	+39.5K sh	—	—	39,500
2025-02-04	IRDOpus Genetics, Inc.F Tax Payment	Head of Fin. Quality Assurance	FTax Payment	−8,190 sh	$1.14	−$9,336.6	74,468
2024-01-18	IRDOpus Genetics, Inc.A Award	Head of Fin. Quality Assurance	AAward	+40K sh	—	—	82,658
2024-01-18	IRDOpus Genetics, Inc. · Employee Stock Option (right to buy)A Award	Head of Fin. Quality Assurance	AAward	+60K sh	—	—	60,000
2024-01-10	IRDOpus Genetics, Inc.F Tax Payment	Head of Fin. Quality Assurance	FTax Payment	−3,950 sh	$3.27	−$12.9K	42,658
2023-01-10	IRDOpus Genetics, Inc.A Award	Head of Fin. Quality Assurance	AAward	+46.6K sh	—	—	46,608
2023-01-10	IRDOpus Genetics, Inc. · Employee Stock Option (right to buy)A Award	Head of Fin. Quality Assurance	AAward	+69.9K sh	—	—	69,912
2022-01-28	IRDOpus Genetics, Inc. · Employee Stock Option (right to buy)A Award	Head of Fin. Quality Assurance	AAward	+50K sh	—	—	50,000
2020-11-11	IRDOpus Genetics, Inc. · Employee Stock Option (right to buy)A Award	Head of Fin. Quality Assurance	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
Apr 274
Zaremba Rabourn Amy0000905148-26-001865
SEC(opens sec.gov)
Mar 184
Zaremba Rabourn Amy0000905148-26-001382
SEC(opens sec.gov)
Jan 264
Zaremba Rabourn Amy0000905148-26-000357
SEC(opens sec.gov)
Jan 214
Zaremba Rabourn Amy0000905148-26-000282
SEC(opens sec.gov)
Jan 134
Zaremba Rabourn Amy0000905148-26-000164
SEC(opens sec.gov)
Mar 174
Zaremba Rabourn Amy0000905148-25-000941
SEC(opens sec.gov)
Feb 64
Zaremba Rabourn Amy0000905148-25-000403
SEC(opens sec.gov)
Jan 224
Zaremba Rabourn Amy0001140361-24-003191
SEC(opens sec.gov)
Jan 124
Zaremba Rabourn Amy0001140361-24-002128
SEC(opens sec.gov)
Jan 124
Zaremba Rabourn Amy0001140361-23-001508
SEC(opens sec.gov)
Feb 14
Zaremba Rabourn Amy0001140361-22-003492
SEC(opens sec.gov)
Nov 164
Zaremba Rabourn Amy0001140361-20-025729
SEC(opens sec.gov)

Companies

Opus Genetics, Inc.Head of Fin. Quality AssuranceIRD

Address

C/O OPUS GENETICS, INC. 8 DAVIS DRIVE, SUITE 220

DURHAM, NC, 27713